Home Stock

Stock Research: Boryung

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Boryung

KSC:003850 KR7003850005
54
  • Value
    92
  • Growth
    55
  • Safety
    Safety
    48
  • Combined
    82
  • Sentiment
    14
  • 360° View
    360° View
    54
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based pharmaceutical company that manufactures and sells various pharmaceutical products. The company operates in the pharmaceutical industry, producing and distributing drugs such as antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, and anticancer drugs. It distributes its products in domestic and overseas markets. In the last fiscal year, the company had a market cap of $524 million, profits of $246 million, and revenue of $689 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 54 (better than 54% compared with alternatives), overall professional sentiment and financial characteristics for the stock Boryung are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Boryung. The consolidated Value Rank has an attractive rank of 92, which means that the share price of Boryung is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 92% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 55, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 14. Professional investors are more confident in 86% other stocks. Worryingly, the company has risky financing, with a Safety rank of 48. This means 52% of comparable companies have a safer financing structure than Boryung. ...read more

more
Strongest Rank Revenue Growth
Weakest Rank Value
Country South Korea
Industry Pharmaceuticals
Size Small
Website boryung.co.kr
Index
KOSPI
Boryung stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 52 48 37
Growth
55 51 83 41
Safety
Safety
48 30 28 28
Sentiment
14 90 92 75
360° View
360° View
54 86 75 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
25 100 100 87
Opinions Change
50 50 50 18
Pro Holdings
n/a 50 56 82
Market Pulse
19 72 80 n/a
Sentiment
14 90 92 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 52 48 37
Growth
55 51 83 41
Safety Safety
48 30 28 28
Combined
82 51 48 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
85 80 85 65
Price vs. Earnings (P/E)
34 63 44 40
Price vs. Book (P/B)
85 48 42 35
Dividend Yield
83 32 35 36
Value
92 52 48 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
12 54 72 55
Profit Growth
34 13 41 64
Capital Growth
78 98 95 49
Stock Returns
73 38 57 23
Growth
55 51 83 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
38 37 27 16
Refinancing
62 46 59 69
Liquidity
55 60 34 34
Safety Safety
48 30 28 28

Similar Stocks

Discover high‑ranked alternatives to Boryung and broaden your portfolio horizons.

Shimadzu

TYO:7701
Country: Japan
Industry: Electronic Equipment
Size: X-Large
Full Stock Analysis

Cosmo Energy Holdings

TYO:5021
Country: Japan
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

NICE Information Service

KSC:030190
Country: South Korea
Industry: Research & Consulting
Size: Medium
Full Stock Analysis

Hyundai Home Shopping Network

KSC:057050
Country: South Korea
Industry: Internet Retail
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews